Filing Details

Accession Number:
0001209191-23-051743
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-03 19:55:09
Reporting Period:
2023-10-02
Accepted Time:
2023-10-03 19:55:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1496323 Igm Biosciences Inc. IGMS Pharmaceutical Preparations (2834) 770349194
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1857434 George Gauthier C/O Igm Biosciences, Inc.
325 E. Middlefield Road
Mountain View CA 94043
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-10-02 935 $7.95 39,082 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan, entered into on December 29, 2022, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  2. This transaction was executed in multiple trades at prices ranging from $7.80 to $8.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.